BOSTON, Dec. 19, 2017 -- HapYak today announced expanded adoption of its interactive video platform in life sciences. With a user base that includes 5 of the top 10 pharmaceutical and medical device companies, HapYak is built to support a broad set of video-enabled business goals, from managing Important Safety Information (ISI) in digital marketing campaigns to internal education.
As the use of video marketing in life sciences continues to grow, studies have shown 95% message recall with video, compared to 10% as text. Video is also highly effective in branding, with 71% of consumers who watched a video saying it left them with a positive impression of the brand, service or company, and 73% of all consumers saying they were more likely to proceed with a purchase after watching videos explaining a product or service.
“Until now, out-of-the-box solutions for managing the user experience with important drug information in online video didn’t exist. Without massive customization, viewers using a standard video platform or player could readily bypass the ISI in marketing campaigns,” said Kyle Morton, HapYak’s chief product officer and co-founder. “And, because multiple video versions were needed for different markets, geographies, languages or indications, code changes are costly and don’t scale. HapYak’s continued investment and innovation addresses these challenges.”
With a secure interactivity and data layer delivered from the cloud, HapYak’ easy-to-use SaaS platform adds interactivity – such as chapters, branching, links and response mechanisms – to any video in minutes. An onboard system-enforced ISI ‘gate’ ensures that healthcare providers, consumers and others are exposed to ISI for a determined period of time before they can freely navigate to other parts of the video. The solution works with any popular video player, CDN or video management system to optimize existing technology investments and deliver deep audience insights.
In recognition of this unique value, HapYak’s interactive video platform was named this week by PM360 Magazine as a top innovation of 2017. As a leading publication for marketing decision makers in life sciences, each year its editors recognize the latest advancements and strategies helping pharmaceutical, biotech and medical device marketers to achieve better results.
“This year’s selections demonstrate our industry’s strong desire to continuously advance every sector of life sciences from development to marketing,” said Anna Stashower, CEO and publisher of PM360.
About HapYak Interactive Video & Data
Used by the world’s top brands, universities and people like you, HapYak’s interactive tools and data connect every video strategy to business results. For more information or to try HapYak for free, visit HapYak.com, or follow us on Twitter, Facebook and LinkedIn.
See the complete list of this year’s PM360 innovators at www.pm360online.com/pm360-presents-the-2017-innovators.
Media Contacts
Lisa Clark
HapYak Interactive Video
[email protected]
978-914-2923
Mary Kae Marinac
MKM Corporate Communications
[email protected]
978-685-3136


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



